Cargando…

Peri‐implantation urinary hormone monitoring distinguishes between types of first‐trimester spontaneous pregnancy loss

BACKGROUND: Lutenising hormone (LH) and human chorionic gonadotropin (hCG) hormone are useful biochemical markers to indicate ovulation and embryonic implantation, respectively. We explored “point‐of‐care” LH and hCG testing using a digital home‐testing device in a cohort trying to conceive. OBJECTI...

Descripción completa

Detalles Bibliográficos
Autores principales: Foo, Lin, Johnson, Sarah, Marriott, Lorrae, Bourne, Tom, Bennett, Phillip, Lees, Christoph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496486/
https://www.ncbi.nlm.nih.gov/pubmed/32056241
http://dx.doi.org/10.1111/ppe.12613
_version_ 1783583107940614144
author Foo, Lin
Johnson, Sarah
Marriott, Lorrae
Bourne, Tom
Bennett, Phillip
Lees, Christoph
author_facet Foo, Lin
Johnson, Sarah
Marriott, Lorrae
Bourne, Tom
Bennett, Phillip
Lees, Christoph
author_sort Foo, Lin
collection PubMed
description BACKGROUND: Lutenising hormone (LH) and human chorionic gonadotropin (hCG) hormone are useful biochemical markers to indicate ovulation and embryonic implantation, respectively. We explored “point‐of‐care” LH and hCG testing using a digital home‐testing device in a cohort trying to conceive. OBJECTIVE: To determine conception and spontaneous pregnancy loss rates, and to assess whether trends in LH‐hCG interval which are known to be associated with pregnancy viability could be identified with point‐of‐care testing. METHODS: We recruited healthy women aged 18‐44 planning a pregnancy. Participants used a home monitor to track LH and hCG levels for 12 menstrual cycles or until pregnancy was conceived. Pregnancy outcomes (viable, clinical miscarriage, or biochemical pregnancy loss) were recorded. Monitor data were analysed by a statistician blinded to pregnancy outcome. RESULTS: From 387 recruits, there were 290 pregnancies with known outcomes within study timeline. Adequate monitor data for analysis were available for 150 conceptive cycles. Overall spontaneous first‐trimester pregnancy loss rate was 30% with clinically recognised miscarriage rate of 17%. The difference to LH‐hCG interval median had wider spread for biochemical losses (0.5‐8.5 days) compared with clinical miscarriage (0‐5 days) and viable pregnancies (0‐6 days). Fixed effect hCG profile change distinguished between pregnancy outcomes from as early as day‐2 post‐hCG rise from baseline. CONCLUSIONS: The risk of first‐trimester spontaneous pregnancy loss in our prospective cohort is comparable to studies utilising daily urinary hCG collection and laboratory assays. A wider LH‐hCG interval range is associated with biochemical pregnancy loss and may relate to late or early implantation. Although early hCG changes discriminate between pregnancies that will miscarry from viable pregnancies, this point‐of‐care testing model is not sufficiently developed to be predictive.
format Online
Article
Text
id pubmed-7496486
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-74964862020-09-25 Peri‐implantation urinary hormone monitoring distinguishes between types of first‐trimester spontaneous pregnancy loss Foo, Lin Johnson, Sarah Marriott, Lorrae Bourne, Tom Bennett, Phillip Lees, Christoph Paediatr Perinat Epidemiol Special Issue: Leveraging Technology BACKGROUND: Lutenising hormone (LH) and human chorionic gonadotropin (hCG) hormone are useful biochemical markers to indicate ovulation and embryonic implantation, respectively. We explored “point‐of‐care” LH and hCG testing using a digital home‐testing device in a cohort trying to conceive. OBJECTIVE: To determine conception and spontaneous pregnancy loss rates, and to assess whether trends in LH‐hCG interval which are known to be associated with pregnancy viability could be identified with point‐of‐care testing. METHODS: We recruited healthy women aged 18‐44 planning a pregnancy. Participants used a home monitor to track LH and hCG levels for 12 menstrual cycles or until pregnancy was conceived. Pregnancy outcomes (viable, clinical miscarriage, or biochemical pregnancy loss) were recorded. Monitor data were analysed by a statistician blinded to pregnancy outcome. RESULTS: From 387 recruits, there were 290 pregnancies with known outcomes within study timeline. Adequate monitor data for analysis were available for 150 conceptive cycles. Overall spontaneous first‐trimester pregnancy loss rate was 30% with clinically recognised miscarriage rate of 17%. The difference to LH‐hCG interval median had wider spread for biochemical losses (0.5‐8.5 days) compared with clinical miscarriage (0‐5 days) and viable pregnancies (0‐6 days). Fixed effect hCG profile change distinguished between pregnancy outcomes from as early as day‐2 post‐hCG rise from baseline. CONCLUSIONS: The risk of first‐trimester spontaneous pregnancy loss in our prospective cohort is comparable to studies utilising daily urinary hCG collection and laboratory assays. A wider LH‐hCG interval range is associated with biochemical pregnancy loss and may relate to late or early implantation. Although early hCG changes discriminate between pregnancies that will miscarry from viable pregnancies, this point‐of‐care testing model is not sufficiently developed to be predictive. John Wiley and Sons Inc. 2020-02-13 2020-09 /pmc/articles/PMC7496486/ /pubmed/32056241 http://dx.doi.org/10.1111/ppe.12613 Text en © 2020 The Authors. Paediatric and Perinatal Epidemiology published by John Wiley & Sons Ltd This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Special Issue: Leveraging Technology
Foo, Lin
Johnson, Sarah
Marriott, Lorrae
Bourne, Tom
Bennett, Phillip
Lees, Christoph
Peri‐implantation urinary hormone monitoring distinguishes between types of first‐trimester spontaneous pregnancy loss
title Peri‐implantation urinary hormone monitoring distinguishes between types of first‐trimester spontaneous pregnancy loss
title_full Peri‐implantation urinary hormone monitoring distinguishes between types of first‐trimester spontaneous pregnancy loss
title_fullStr Peri‐implantation urinary hormone monitoring distinguishes between types of first‐trimester spontaneous pregnancy loss
title_full_unstemmed Peri‐implantation urinary hormone monitoring distinguishes between types of first‐trimester spontaneous pregnancy loss
title_short Peri‐implantation urinary hormone monitoring distinguishes between types of first‐trimester spontaneous pregnancy loss
title_sort peri‐implantation urinary hormone monitoring distinguishes between types of first‐trimester spontaneous pregnancy loss
topic Special Issue: Leveraging Technology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496486/
https://www.ncbi.nlm.nih.gov/pubmed/32056241
http://dx.doi.org/10.1111/ppe.12613
work_keys_str_mv AT foolin periimplantationurinaryhormonemonitoringdistinguishesbetweentypesoffirsttrimesterspontaneouspregnancyloss
AT johnsonsarah periimplantationurinaryhormonemonitoringdistinguishesbetweentypesoffirsttrimesterspontaneouspregnancyloss
AT marriottlorrae periimplantationurinaryhormonemonitoringdistinguishesbetweentypesoffirsttrimesterspontaneouspregnancyloss
AT bournetom periimplantationurinaryhormonemonitoringdistinguishesbetweentypesoffirsttrimesterspontaneouspregnancyloss
AT bennettphillip periimplantationurinaryhormonemonitoringdistinguishesbetweentypesoffirsttrimesterspontaneouspregnancyloss
AT leeschristoph periimplantationurinaryhormonemonitoringdistinguishesbetweentypesoffirsttrimesterspontaneouspregnancyloss